has been refreshed! Take a tour.
  • Meningococcal ACWY
  • Booster Doses

If a child with a high-risk condition receives MenACWY at age 9 years (and a second primary dose 8 weeks later), should they receive a booster dose at age 14 years (5 years after the primary series), or should they receive a dose at age 16 years as recommended in the routine schedule?

The MenACWY booster dose should be given at 14 years (5 years after the primary series) and every 5 years thereafter. The every 5-year booster dose schedule for people with high-risk conditions takes precedence over the routine adolescent schedule.

Last reviewed: July 15, 2023

This page was updated on .